Universal hepatitis B virus vaccination in french prisons: Breaking down the last barriers

Addiction

Volumn 105, Issue 7, 2010, Pages 1311-1312

  Carrieri, M Patrizia ^a,b   Rey, Dominique ^a,b   Michel, Laurent ^c,d,e  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Universite Paris Sud   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e Emile Roux Hospital AP HP   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FRANCE; HEPATITIS B; HUMAN; MASS IMMUNIZATION; NOTE; PRISON;

FRANCE; HEPATITIS B; HUMANS; MASS VACCINATION; PRISONS;

EID: 77953315635     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.02968.x     Document Type: Letter

References (12)

1. Larney S. Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review. Addiction 2010 105 : 216 223.
2. Farrell M., Strang J., Stover H. Hepatitis B vaccination in prisons: a much-needed targeted universal intervention. Addiction 2010 105 : 189 190.
3. Backmund M., Meyer K., Schuetz C., Reimer J. Factors associated with exposure to hepatitis B virus in injection drug users. Drug Alcohol Depend 2006 84 : 154 159.
4. Sutton A. J., Gay N. J., Edmunds W. J. Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales. Vaccine 2006 24 : 2377 2386.
5. Six C., Hamers F., Brunet J. B. Infections à VIH, VHC et VHB chez les résidents des centres de soins spécialisés pour toxicomanes avec hébergement 1993-1998 [HIV, HCV and HBV infections in residential centres for care of drug dependence, 1993-1998]. Bull Epidemiol Hebdomadaire 1999 32 : 133 135.
6. Sunthornchart S., Linkins R. W., Natephisarnwanish V., Levine W. C., Maneesinthu K., Lolekha R. et al. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005. Addiction 2008 103 : 1687 1695.
7. Gilbert R. L., Costella A., Piper M., Gill O. N. Increasing hepatitis B vaccine coverage in prisons in England and Wales. Commun Dis Public Health 2004 7 : 306 311.
8. Mikaeloff Y., Caridade G., Suissa S., Tardieu M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2009 72 : 873 880.
9. Michel L., Carrieri M. P., Wodak A. Harm reduction and equity of access to care for French prisoners: a review. Harm Reduct J 2008 5 : 17.
10. HAS. Consensus conference: vaccination against hepatitis B virus. 2003. Available at: http://www.has-sante.fr/portail/upload/docs/application/pdf/ Hepatitis-B-guidelines.pdf
11. HAS. Vaccination contre le virus de l'hépatite B et sclérose en plaques: état des lieux [HBV vaccination and multiple sclerosis: state of the art]. 2004. Available at: http://www.snfge.asso.fr/01- Bibliotheque/0D-Pratiques-cliniques/HAS/VHB-SEP.pdf
12. Marchou B., Excler J. L., Bourderioux C., Salaun J., Picot N., Yvonnet B. et al. A 3-week hepatitis B vaccination schedule provides rapid and persistent protective immunity: a multicenter, randomized trial comparing accelerated and classic vaccination schedules. J Infect Dis 1995 172 : 258 260.